table of content
1 Introduction to Research & Analysis Reports
1.1 Drugs for Oncology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Oncology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Oncology Overall Market Size
2.1 Global Drugs for Oncology Market Size: 2023 VS 2030
2.2 Global Drugs for Oncology Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs for Oncology Players in Global Market
3.2 Top Global Drugs for Oncology Companies Ranked by Revenue
3.3 Global Drugs for Oncology Revenue by Companies
3.4 Top 3 and Top 5 Drugs for Oncology Companies in Global Market, by Revenue in 2023
3.5 Global Companies Drugs for Oncology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs for Oncology Players in Global Market
3.6.1 List of Global Tier 1 Drugs for Oncology Companies
3.6.2 List of Global Tier 2 and Tier 3 Drugs for Oncology Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Drugs for Oncology Market Size Markets, 2023 & 2030
4.1.2 Chemotherapy
4.1.3 Targeted Therapy
4.1.4 Immunotherapy (Biologic Therapy)
4.1.5 Hormonal Therapy
4.1.6 Others
4.2 By Type - Global Drugs for Oncology Revenue & Forecasts
4.2.1 By Type - Global Drugs for Oncology Revenue, 2019-2024
4.2.2 By Type - Global Drugs for Oncology Revenue, 2025-2030
4.2.3 By Type - Global Drugs for Oncology Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs for Oncology Market Size, 2023 & 2030
5.1.2 Blood Cancer
5.1.3 Breast Cancer
5.1.4 Gastrointestinal Cancer
5.1.5 Prostate Cancer
5.1.6 Respiratory/Lung Cancer
5.1.7 Others
5.2 By Application - Global Drugs for Oncology Revenue & Forecasts
5.2.1 By Application - Global Drugs for Oncology Revenue, 2019-2024
5.2.2 By Application - Global Drugs for Oncology Revenue, 2025-2030
5.2.3 By Application - Global Drugs for Oncology Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Drugs for Oncology Market Size, 2023 & 2030
6.2 By Region - Global Drugs for Oncology Revenue & Forecasts
6.2.1 By Region - Global Drugs for Oncology Revenue, 2019-2024
6.2.2 By Region - Global Drugs for Oncology Revenue, 2025-2030
6.2.3 By Region - Global Drugs for Oncology Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Drugs for Oncology Revenue, 2019-2030
6.3.2 US Drugs for Oncology Market Size, 2019-2030
6.3.3 Canada Drugs for Oncology Market Size, 2019-2030
6.3.4 Mexico Drugs for Oncology Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Drugs for Oncology Revenue, 2019-2030
6.4.2 Germany Drugs for Oncology Market Size, 2019-2030
6.4.3 France Drugs for Oncology Market Size, 2019-2030
6.4.4 U.K. Drugs for Oncology Market Size, 2019-2030
6.4.5 Italy Drugs for Oncology Market Size, 2019-2030
6.4.6 Russia Drugs for Oncology Market Size, 2019-2030
6.4.7 Nordic Countries Drugs for Oncology Market Size, 2019-2030
6.4.8 Benelux Drugs for Oncology Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Drugs for Oncology Revenue, 2019-2030
6.5.2 China Drugs for Oncology Market Size, 2019-2030
6.5.3 Japan Drugs for Oncology Market Size, 2019-2030
6.5.4 South Korea Drugs for Oncology Market Size, 2019-2030
6.5.5 Southeast Asia Drugs for Oncology Market Size, 2019-2030
6.5.6 India Drugs for Oncology Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Drugs for Oncology Revenue, 2019-2030
6.6.2 Brazil Drugs for Oncology Market Size, 2019-2030
6.6.3 Argentina Drugs for Oncology Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drugs for Oncology Revenue, 2019-2030
6.7.2 Turkey Drugs for Oncology Market Size, 2019-2030
6.7.3 Israel Drugs for Oncology Market Size, 2019-2030
6.7.4 Saudi Arabia Drugs for Oncology Market Size, 2019-2030
6.7.5 UAE Drugs for Oncology Market Size, 2019-2030
7 Drugs for Oncology Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Drugs for Oncology Major Product Offerings
7.1.4 Roche Drugs for Oncology Revenue in Global Market (2019-2024)
7.1.5 Roche Key News & Latest Developments
7.2 Celgene
7.2.1 Celgene Company Summary
7.2.2 Celgene Business Overview
7.2.3 Celgene Drugs for Oncology Major Product Offerings
7.2.4 Celgene Drugs for Oncology Revenue in Global Market (2019-2024)
7.2.5 Celgene Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Drugs for Oncology Major Product Offerings
7.3.4 Novartis Drugs for Oncology Revenue in Global Market (2019-2024)
7.3.5 Novartis Key News & Latest Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Drugs for Oncology Major Product Offerings
7.4.4 Bristol-Myers Squibb Drugs for Oncology Revenue in Global Market (2019-2024)
7.4.5 Bristol-Myers Squibb Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Drugs for Oncology Major Product Offerings
7.5.4 Johnson & Johnson Drugs for Oncology Revenue in Global Market (2019-2024)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Merck & Co.
7.6.1 Merck & Co. Company Summary
7.6.2 Merck & Co. Business Overview
7.6.3 Merck & Co. Drugs for Oncology Major Product Offerings
7.6.4 Merck & Co. Drugs for Oncology Revenue in Global Market (2019-2024)
7.6.5 Merck & Co. Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Drugs for Oncology Major Product Offerings
7.7.4 AstraZeneca Drugs for Oncology Revenue in Global Market (2019-2024)
7.7.5 AstraZeneca Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Drugs for Oncology Major Product Offerings
7.8.4 Pfizer Drugs for Oncology Revenue in Global Market (2019-2024)
7.8.5 Pfizer Key News & Latest Developments
7.9 Amgen
7.9.1 Amgen Company Summary
7.9.2 Amgen Business Overview
7.9.3 Amgen Drugs for Oncology Major Product Offerings
7.9.4 Amgen Drugs for Oncology Revenue in Global Market (2019-2024)
7.9.5 Amgen Key News & Latest Developments
7.10 Eli Lilly
7.10.1 Eli Lilly Company Summary
7.10.2 Eli Lilly Business Overview
7.10.3 Eli Lilly Drugs for Oncology Major Product Offerings
7.10.4 Eli Lilly Drugs for Oncology Revenue in Global Market (2019-2024)
7.10.5 Eli Lilly Key News & Latest Developments
7.11 AbbVie
7.11.1 AbbVie Company Summary
7.11.2 AbbVie Business Overview
7.11.3 AbbVie Drugs for Oncology Major Product Offerings
7.11.4 AbbVie Drugs for Oncology Revenue in Global Market (2019-2024)
7.11.5 AbbVie Key News & Latest Developments
7.12 Takeda
7.12.1 Takeda Company Summary
7.12.2 Takeda Business Overview
7.12.3 Takeda Drugs for Oncology Major Product Offerings
7.12.4 Takeda Drugs for Oncology Revenue in Global Market (2019-2024)
7.12.5 Takeda Key News & Latest Developments
7.13 Astellas
7.13.1 Astellas Company Summary
7.13.2 Astellas Business Overview
7.13.3 Astellas Drugs for Oncology Major Product Offerings
7.13.4 Astellas Drugs for Oncology Revenue in Global Market (2019-2024)
7.13.5 Astellas Key News & Latest Developments
7.14 Ipsen
7.14.1 Ipsen Company Summary
7.14.2 Ipsen Business Overview
7.14.3 Ipsen Drugs for Oncology Major Product Offerings
7.14.4 Ipsen Drugs for Oncology Revenue in Global Market (2019-2024)
7.14.5 Ipsen Key News & Latest Developments
7.15 Sanofi
7.15.1 Sanofi Company Summary
7.15.2 Sanofi Business Overview
7.15.3 Sanofi Drugs for Oncology Major Product Offerings
7.15.4 Sanofi Drugs for Oncology Revenue in Global Market (2019-2024)
7.15.5 Sanofi Key News & Latest Developments
7.16 Bayer
7.16.1 Bayer Company Summary
7.16.2 Bayer Business Overview
7.16.3 Bayer Drugs for Oncology Major Product Offerings
7.16.4 Bayer Drugs for Oncology Revenue in Global Market (2019-2024)
7.16.5 Bayer Key News & Latest Developments
7.17 Biogen Idec
7.17.1 Biogen Idec Company Summary
7.17.2 Biogen Idec Business Overview
7.17.3 Biogen Idec Drugs for Oncology Major Product Offerings
7.17.4 Biogen Idec Drugs for Oncology Revenue in Global Market (2019-2024)
7.17.5 Biogen Idec Key News & Latest Developments
7.18 Teva
7.18.1 Teva Company Summary
7.18.2 Teva Business Overview
7.18.3 Teva Drugs for Oncology Major Product Offerings
7.18.4 Teva Drugs for Oncology Revenue in Global Market (2019-2024)
7.18.5 Teva Key News & Latest Developments
7.19 Otsuka
7.19.1 Otsuka Company Summary
7.19.2 Otsuka Business Overview
7.19.3 Otsuka Drugs for Oncology Major Product Offerings
7.19.4 Otsuka Drugs for Oncology Revenue in Global Market (2019-2024)
7.19.5 Otsuka Key News & Latest Developments
7.20 Eisai
7.20.1 Eisai Company Summary
7.20.2 Eisai Business Overview
7.20.3 Eisai Drugs for Oncology Major Product Offerings
7.20.4 Eisai Drugs for Oncology Revenue in Global Market (2019-2024)
7.20.5 Eisai Key News & Latest Developments
7.21 Merck KGaA
7.21.1 Merck KGaA Company Summary
7.21.2 Merck KGaA Business Overview
7.21.3 Merck KGaA Drugs for Oncology Major Product Offerings
7.21.4 Merck KGaA Drugs for Oncology Revenue in Global Market (2019-2024)
7.21.5 Merck KGaA Key News & Latest Developments
7.22 Gilead Sciences
7.22.1 Gilead Sciences Company Summary
7.22.2 Gilead Sciences Business Overview
7.22.3 Gilead Sciences Drugs for Oncology Major Product Offerings
7.22.4 Gilead Sciences Drugs for Oncology Revenue in Global Market (2019-2024)
7.22.5 Gilead Sciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
